introduct
aim
although
guidelin
recommend
salt
restrict
studi
examin
associ
salt
restrict
clinic
outcom
hemodialysi
hd
patient
method
conduct
retrospect
cohort
studi
adult
patient
enrol
japanes
societi
dialysi
therapi
jsdt
registri
receiv
hd
least
two
year
consid
anur
primari
outcom
measur
allcaus
mortal
one
year
secondari
outcom
cardiovascular
cv
mortal
estim
salt
intak
main
predictor
calcul
interdialyt
weight
gain
preand
postdialysi
serum
sodium
level
accord
valid
method
kimura
ramdeen
nonlinear
logist
regress
use
determin
associ
salt
intak
mortal
adjust
age
gender
bodi
mass
index
vintag
hd
dialysi
time
ktv
protein
catabol
rate
normal
bodi
weight
comorbid
condit
type
vascular
access
serum
potassium
phosphat
calcium
crp
level
endotoxin
level
dialys
cubic
spline
plot
refer
median
salt
intak
salt
consumpt
categor
intak
level
g
per
day
associ
mortal
examin
result
median
percentil
salt
intak
baselin
g
per
day
one
year
allcaus
mortal
occur
patient
includ
cardiovascular
mortal
observ
associ
low
salt
intak
clinic
outcom
allcaus
cv
mortal
observ
highest
allcaus
mortal
low
salt
group
associ
allcaus
mortal
high
salt
intak
observ
similar
associ
salt
intak
cv
mortal
conclus
low
salt
intak
associ
allcaus
cv
mortal
find
support
current
clinic
guidelin
recommend
restrict
salt
intak
less
per
day
introduct
aim
epidemiolog
data
demonstr
elev
cancer
risk
hemodialysi
hd
patient
aim
present
studi
evalu
demograph
clinic
biochem
determin
cancer
develop
hd
patient
method
monitor
dialysi
outcom
mondo
consortium
consist
hd
databas
renal
research
institut
rri
clinic
us
freseniu
medic
care
fmc
clinic
europ
asia
pacif
ap
latin
america
la
kfh
clinic
germani
imperi
colleg
london
uk
hadassah
medic
center
jerusalem
israel
univers
maastricht
netherland
extract
data
patient
surviv
least
month
start
hd
ninetyfour
hd
patient
preexist
cancer
exclud
analysi
use
avail
variabl
construct
regress
model
predict
cancer
develop
year
followup
candid
predictor
includ
demograph
characterist
age
sex
comorbid
diabet
hypertens
cardiovascular
diseas
cvd
coronari
arteri
diseas
cad
smoke
bodi
mass
index
bmi
dialysi
paramet
ektv
urea
reduct
ratio
urr
vascular
access
erythropoietin
dosag
intradialyt
weight
gain
idwg
normal
protein
catabol
ratio
npcr
laboratori
test
albumin
hemoglobin
hgb
sodium
potassium
calcium
phosphoru
ferritin
serum
creatinin
scr
white
blood
cell
count
platelet
total
cholesterol
continu
variabl
convert
categor
one
base
optim
clinic
cut
point
preprocess
step
categor
variabl
prescreen
use
chisquar
test
p
stepwis
forward
method
use
variabl
select
multipl
logist
regress
result
hd
patient
studi
eastern
europ
western
europ
northern
europ
southern
europ
western
asia
mean
sd
age
year
male
overal
incid
cancer
case
case
hd
patient
cancerrel
death
incid
cancer
highest
eastern
europ
case
lowest
western
case
northern
europ
case
men
older
year
trend
toward
higher
cancer
incid
compar
older
femal
vs
p
multivari
logist
regress
model
predict
twoyear
risk
cancer
retain
follow
variabl
age
bmi
ferritin
albumin
hgb
ektv
vascular
access
cad
diabet
idwg
model
signific
predictor
unstandard
coeffici
ci
present
tabl
conclus
studi
identifi
clinic
relev
risk
factor
predict
cancer
hd
patient
risk
assess
model
could
help
clinician
stratifi
patient
cancer
screen
surveil
prevent
earli
therapeut
intervent
studi
need
valid
model
extern
deriv
cohort
evalu
generaliz
introduct
aim
assist
periton
dialysi
apd
avail
altern
hospit
haemodialysi
hd
frail
older
patient
lack
outcom
data
compar
hd
apd
limit
use
fepod
part
report
signific
differ
primari
outcom
qualiti
life
physic
function
except
higher
preval
possibl
depress
apd
group
report
describ
secondari
outcom
studi
group
secondari
outcom
hospitalis
fall
symptom
burden
cognit
patient
satisfact
method
apd
patient
hd
patient
recruit
centr
hd
patient
match
recruit
apd
particip
age
sex
diabet
statu
time
dialysi
ethnic
index
depriv
miniment
state
examin
mmse
trail
make
form
b
use
assess
global
cognit
function
execut
function
respect
fall
symptom
burden
assess
use
fall
questionnair
palli
outcom
symptom
scale
renal
respect
patient
satisfact
measur
use
renal
treatment
satisfact
questionnair
result
patient
hd
apd
recruit
studi
group
least
one
hospit
admiss
preced
three
month
admiss
dialysi
relat
studi
group
least
one
fall
preced
three
occur
home
hd
group
sustain
fractur
apd
group
hd
vs
apd
lethargi
pain
poor
mobil
predomin
studi
group
median
number
report
symptom
iqr
hd
group
iqr
apd
group
hd
patient
report
improv
symptom
sinc
start
dialysi
apd
group
studi
group
abnorm
mmse
score
statist
differ
mmse
score
hd
patient
apd
patient
mean
apd
contrast
execut
dysfunct
trail
make
b
test
time
second
execut
dysfunct
preval
apd
group
apd
vs
hd
p
despit
outcom
studi
group
would
recommend
therapi
other
mean
total
renal
treatment
satisfact
score
hd
vs
apd
conclus
high
preval
fall
symptom
burden
execut
dysfunct
hospitalis
frail
elderli
dialysi
patient
irrespect
dialysi
modal
consid
discuss
renal
replac
modal
includ
nondialyt
care
fepod
part
longitudin
phase
studi
provid
inform
influenc
dialysi
modal
trajectori
outcom
introduct
aim
mortal
morbid
first
day
hd
indic
predialysi
care
patient
statu
hd
initi
explor
associ
earli
predictor
ie
factor
captur
first
day
hd
hospit
first
year
hd
larg
intern
sampl
incid
hd
patient
result
among
patient
underw
adiponectin
measur
mean
sd
mcgml
rang
mcgml
mean
sd
age
cohort
year
femal
africanamerican
diabet
compar
lowest
adiponectin
tertil
highest
adiponectin
tertil
associ
increas
allcaus
mortal
risk
adjust
casemix
casemix
laboratori
adjust
model
tabl
second
adiponectin
tertil
associ
numer
greater
risk
estim
statist
signific
sensit
analys
examin
adiponectin
continu
variabl
observ
increment
higher
adiponectin
level
associ
increas
death
risk
tabl
figur
conclus
higher
circul
adiponectin
level
hemodialysi
patient
paradox
associ
higher
allcaus
mortal
futur
studi
need
confirm
find
elucid
mechanist
pathway
introduct
aim
infecti
complic
among
dialysi
patient
major
caus
morbid
noncardiovascular
mortal
dialysi
modal
hypothes
potenti
immunomodulatori
factor
object
studi
investig
associ
dialysi
modal
risk
overal
specif
infecti
complic
distinguish
risk
dialysi
techniqu
nondialysi
techniqu
relat
infect
method
studi
conduct
netherland
cooper
studi
adequaci
dialysi
necosad
cohort
consist
incid
dialysi
patient
cohort
data
infecti
complic
patient
univers
teach
hospit
region
hospit
retrospect
collect
use
strictli
prespecifi
criteria
inform
incid
natur
infect
collect
dialysi
start
death
modal
switch
withdraw
studi
transfer
anoth
dialysi
center
kidney
transplant
end
studi
follow
agestandard
incid
rate
infect
calcul
poisson
regress
use
calcul
incid
rate
ratio
adjust
age
sex
diabet
bmi
kahn
comorbid
score
primari
kidney
diseas
ethnic
malign
chronic
pulmonari
diseas
educ
level
result
total
patient
complet
medic
record
includ
start
haemodialysi
hd
periton
dialysi
pd
median
followup
time
first
dialysi
modal
similar
hd
pd
year
first
month
agestandard
infect
incid
rate
significantli
higher
hd
introduct
aim
increas
evid
show
high
dose
haemodialysi
frequent
andor
longer
durat
hemodialysi
hd
improv
clinic
humanist
outcom
compar
expect
health
gain
measur
lifeyear
ly
qualityadjust
lifeyear
qali
gain
high
dose
hd
home
dialysi
modal
use
greater
proport
dialysi
patient
current
observ
method
markov
model
built
uk
environ
variou
combin
high
dose
hd
incent
home
periton
dialysi
pd
compar
current
usag
ie
convent
incent
hd
pd
convent
home
hd
high
dose
home
hd
input
includ
incid
preval
transplant
rate
uk
renal
registri
complic
util
transit
modal
medic
literatur
surviv
pd
convent
hd
eraedta
registri
high
dose
hd
medic
literatur
model
run
year
preval
dialysi
popul
incid
cohort
enter
model
year
year
result
period
scenario
patient
receiv
incent
convent
hd
gener
loss
ly
qali
cohort
treat
patient
high
dose
hd
incent
home
although
like
unrealist
increas
cohort
ly
qali
less
extrem
scenario
led
increas
ly
qali
gain
increas
usag
home
modal
realist
scenario
patient
receiv
high
dose
hd
home
pd
usag
back
year
level
ie
gener
ly
qali
gain
conclus
analysi
show
high
dose
hd
especi
perform
home
potenti
significantli
increas
health
gain
dialysi
popul
analysi
also
show
treat
increas
incent
hd
patient
popul
result
health
loss
til
leimbach
joachim
kron
jutta
czerni
birgit
urbach
sabin
aign
susann
kron
kfhnierenzentrum
berlin
germani
charit
berlin
berlin
germani
introduct
aim
germani
everi
fifth
incid
dialysi
patient
current
year
age
older
question
aris
longer
treat
patient
method
singl
centr
data
dialysi
patient
age
year
analyz
regard
surviv
social
circumst
vascular
access
predialysi
nephrolog
care
result
patient
year
age
start
chronic
ambulatori
haemodialysi
treatment
oneyear
surviv
surviv
surviv
surviv
respect
patient
n
month
nephrolog
care
prior
dialysi
month
median
month
surviv
significantli
longer
patient
less
month
contact
nephrologist
decemb
patient
femal
male
age
year
median
age
year
year
chronic
haemodialysi
program
thu
account
dialysi
patient
centr
median
durat
dialysi
month
month
patient
two
patient
live
home
patient
singl
spous
patient
live
rel
patient
nurs
home
resid
concern
vascular
access
patient
nativ
avfistula
graft
patient
cathet
respect
vascular
access
use
month
month
access
complic
occur
patient
case
new
vascular
access
establish
graft
cathet
consequenti
one
access
lost
patient
year
dialysi
compar
incentr
patient
one
loss
patient
year
elderli
suffer
less
access
failur
overal
prior
start
dialysi
patient
longterm
nephrolog
care
month
median
month
patient
refer
late
month
prior
first
dialysi
patient
dialysi
start
follow
emerg
referr
hospit
patient
start
first
dialysi
treatment
function
shunt
access
perman
cathet
temporari
cathet
conclus
life
expect
social
statu
patient
start
dialysi
age
year
older
nearli
compar
gener
popul
age
longterm
predialysi
nephrolog
care
import
success
dialysi
treatment
elderli
especi
octogenarian
nonagenarian
earli
establish
function
vascular
access
care
schedul
first
dialysi
treatment
reduc
complic
increas
surviv
qualiti
live
use
cathet
avoid
almost
patient
year
introduct
aim
haemodialysi
hd
common
dialysi
modal
frail
older
patient
although
mani
toler
poorli
transport
problem
assist
periton
dialysi
apd
increasingli
avail
enabl
home
treatment
data
patient
outcom
apd
compar
hd
studi
design
part
part
crosssect
studi
obtain
snapshot
view
patient
wellb
apd
compar
hd
part
prospect
longitudin
studi
determin
patient
outcom
year
report
focus
result
part
primari
outcom
comparison
qualiti
life
physic
function
preval
frail
older
patient
apd
hd
method
apd
patient
defin
requir
assist
perform
pd
paid
unpaid
carer
hd
patient
requir
hospit
transport
recruit
centr
year
dialysi
month
free
hospitalis
day
hd
elig
patient
match
recruit
apd
particip
age
year
sex
diabet
statu
time
dialysi
year
ethnic
index
depriv
qualiti
life
assess
made
use
hospit
anxieti
depress
scale
had
palli
outcom
symptom
scale
ill
intrus
rate
scale
physic
function
assess
barthel
score
measur
aid
daili
live
time
go
result
apd
match
hd
patient
studi
mean
age
year
respect
presenc
frailti
similar
modal
apd
hd
multivari
analys
pvalu
deriv
generalis
linear
model
show
frailti
score
influenti
variabl
relat
outcom
sf
physic
sf
mental
barthel
p
time
go
p
dialysi
modal
influenti
variabl
determin
total
had
score
mean
apd
hd
symptom
score
median
apd
hd
use
propens
score
deriv
age
gender
frailti
comorbid
score
compar
pair
particip
apd
hd
show
significantli
higher
had
score
apd
remain
symptom
score
probabl
depress
had
also
common
apd
group
conclus
degre
frailti
major
determin
qualiti
life
physic
function
dialysi
modal
minor
role
probabl
slightli
depress
apd
group
need
confirm
larger
longitudin
studi
apd
hd
therefor
discuss
potenti
modal
leav
choic
individu
patient
ikuto
masakan
ehop
studi
group
yabuki
hospit
yamagata
japan
introduct
aim
sever
recent
report
warn
high
effici
hemodialysi
polysulfon
ps
membran
occasion
led
deterior
nutrit
statu
elder
patient
ethylen
vinyl
alcohol
eval
membran
high
biocompat
broad
solut
remov
properti
efficaci
urem
solut
less
ps
prior
studi
eval
membran
improv
deteriol
nutrit
statu
caus
ps
membran
ehopoedstudi
group
establish
determin
best
dialyz
choic
elder
dialysi
patient
earli
dialysi
stage
method
ehopedstudi
openlabel
dynam
alloc
central
registr
random
control
trial
perform
dialysi
facil
japan
patient
accept
enrol
studi
randomli
divid
next
two
group
group
treat
eval
membran
group
b
treat
sever
high
flux
membran
ps
entri
criteria
patient
age
year
old
dialysi
vintag
less
day
patient
registr
finish
dec
final
patient
patient
group
group
b
enrol
studi
yearsurviv
chang
nutrit
statu
occurr
complic
other
end
point
dimograph
data
patient
interim
analysi
patient
whose
clinic
data
could
follow
longer
month
includ
studi
nephrologist
often
face
difficult
treatment
recommend
elderli
end
stage
kidney
diseas
eskd
patient
respect
dialysi
versu
support
nondialysi
care
given
uncertainti
around
surviv
benefit
consider
treatment
burden
aim
defin
nephrologist
prefer
dialysi
recommend
elderli
patient
assess
tradeoff
patient
characterist
method
conduct
discret
choic
experi
dce
australasian
nephrologist
dce
design
inform
rank
exercis
characterist
deriv
literatur
pilot
dce
nephrologist
assess
influenc
patient
characterist
age
gender
cognit
comorbid
burden
life
expect
current
qualiti
life
qol
expect
qol
chang
dialysi
social
support
patient
famili
inclin
dialysi
nephrologist
prefer
dialysi
recommend
onlin
dce
consist
scenario
two
elderli
patient
describ
term
characterist
nephrologist
ask
hypothet
patient
would
prefer
recommend
dialysi
whether
would
recommend
dialysi
neither
patient
respond
sociodemograph
characterist
also
collect
analysi
use
random
paramet
logit
model
result
odd
recommend
dialysi
dialysi
margin
rate
substitut
tradeoff
qol
surviv
calcul
result
nephrologist
particip
dce
roughli
one
third
age
male
caucasian
nephrologist
chose
neither
patient
scenario
patient
characterist
gender
significantli
affect
likelihood
dialysi
recommend
nephrologist
like
recommend
dialysi
patient
preserv
cognit
lower
comorbid
burden
increas
life
expect
high
current
qol
patient
famili
inclin
dialysi
also
favour
dialysi
recommend
nephrologist
less
like
recommend
dialysi
extra
year
age
dialysi
expect
decreas
qol
nephrologist
age
almost
time
like
recommend
dialysi
compar
younger
counterpart
nephrologist
will
forgo
month
patient
dialysi
surviv
order
avoid
substanti
decreas
patient
qol
dialysi
initi
conclus
mani
patient
characterist
consid
nephrologist
recommend
dialysi
nephrologist
much
like
recommend
dialysi
normal
cognit
inclin
dialysi
avoid
recommend
dialysi
initi
expect
consider
reduc
qol
find
highlight
need
systemat
longitudin
evalu
cognit
qol
contempl
dialysi
decis
elderli
patient
introduct
aim
hypertens
poorli
control
patient
haemodialysi
hd
hypertens
predictor
cardiovascular
mortal
hd
patient
patient
thriceweekli
hd
higher
predialysi
weight
pwg
ultrafiltr
rate
uf
first
compar
subsequ
hd
week
hypothes
variat
pwg
uf
associ
systemat
differ
blood
pressur
aim
studi
examin
mean
arteri
pressur
map
puls
pressur
pp
hd
patient
assess
relationship
paramet
pwg
uf
method
studi
patient
age
year
maintain
hd
year
includ
male
femal
dalmatian
centr
dalmatia
counti
southern
croatia
blood
pressur
measur
undertaken
first
hd
session
begin
observ
week
everi
singl
observ
hd
mean
arteri
pressur
map
calcul
systol
diastol
blood
pressur
mmhg
puls
pressur
pp
comput
systol
diastol
blood
pressur
mmhg
predialysi
postdialysi
measur
therefor
pwg
uf
rate
calcul
averag
valu
week
hd
treatment
prior
ti
studi
result
result
show
influenc
pwg
uf
blood
pressur
hd
patient
statist
signific
correl
averag
pwg
post
hd
map
valu
r
indic
higher
pwg
lead
hemodynam
instabl
lower
blood
pressur
hd
patient
hd
treatment
also
higher
uf
rate
significantli
correl
lower
map
pp
hd
treatment
shown
tabl
conclus
restrict
pwg
control
uf
rate
hd
session
import
becous
two
paramet
might
influenc
blood
pressur
paramet
hd
patient
well
known
poor
blood
pressur
control
hd
patient
lead
increas
cardiovascular
morbid
mortal
reserch
evaluet
improv
blood
pressur
paramet
hemodianam
stabil
patient
pwg
restrict
lower
uf
rate
person
health
record
epr
design
educ
patient
well
enabl
particip
monitor
manag
renal
diseas
uk
may
therefor
role
equip
patient
make
inform
choic
dialysi
modal
begin
rrt
one
key
standard
propos
nation
servic
framework
nsf
renal
servic
patient
offer
inform
choic
choos
homebas
modal
predialysi
educ
report
strengthen
trend
background
hypothesis
patient
utilis
rpv
better
inform
choic
modal
like
choos
homebas
modal
first
rrt
provis
aim
investig
first
dialysi
modal
rpv
user
nonus
method
rpv
user
databas
extant
januari
link
patient
chi
nh
number
uk
renal
registri
anonymis
data
extract
analysi
extract
restrict
adult
patient
includ
patient
demographi
depriv
indic
ethnic
ukrr
timelin
data
referr
time
time
first
referr
nephrologist
date
start
rrt
date
begin
rrt
date
first
logon
rpv
measur
patient
utilis
rpv
deriv
log
file
analysi
report
elsewher
patient
referr
time
day
exclud
rpv
user
group
interv
first
logon
rpv
date
start
rrt
comparison
made
patient
user
rpv
least
day
begin
rrt
longer
term
user
user
began
use
rpv
start
rrt
late
user
logist
regress
chisquar
test
perform
use
sa
v
result
longer
term
rpv
user
like
late
user
begin
rrt
home
base
modal
home
haemodialysi
periton
dialysi
hospit
haemodialysi
respect
p
associ
stronger
longer
term
user
log
rpv
persist
suggest
effect
relat
patient
rather
select
centr
patient
offer
rpv
p
day
start
rrt
differ
preval
homebas
modal
provis
longer
term
late
rpv
user
wane
still
signific
p
persist
rpv
user
result
proxi
longer
referr
period
time
initi
rpv
similar
pattern
found
patient
referr
time
month
year
exclud
control
age
sex
depriv
ethnic
longer
term
persist
rpv
user
ci
like
begin
rrt
homebas
modal
late
user
almost
three
time
like
overal
rrt
popul
longer
term
rpv
user
like
begin
rrt
live
transplant
compar
late
user
respect
p
even
control
age
sex
depriv
similarli
associ
weaken
day
start
rrt
p
result
demonstr
associ
use
rpv
begin
rrt
homebas
modal
live
donor
transplant
greater
strength
associ
user
make
greater
use
rpv
consist
hypothesi
rpv
contribut
patient
discoveri
around
rrt
modal
choic
introduct
aim
approxim
patient
receiv
renal
replac
therapi
rrt
endstag
renal
diseas
esrd
uk
result
substanti
econom
burden
evid
suggest
high
dose
haemodialysi
frequent
andor
longer
durat
hemodialysi
hd
may
associ
better
health
outcom
cost
save
uk
conduct
home
current
tariff
versu
convent
incentr
hd
ichd
howev
current
weekli
tariff
home
dialysi
uk
reflect
increas
product
cost
associ
increas
number
dialysi
session
per
week
investig
financi
impact
increas
proport
esrd
patient
homebas
dialysi
modal
especi
high
dose
hd
home
increas
tariff
uk
payer
perspect
method
markov
model
construct
reflect
natur
histori
dialysi
patient
base
budget
impact
analysi
perform
time
horizon
perspect
english
nation
health
servic
nh
introduct
aim
low
free
triiodothyronin
larg
epiphenomenon
inflamm
proteinenergi
wast
strong
predictor
mortal
endstag
kidney
diseas
eskd
fibrinogen
marker
inflamm
key
molecul
transduc
effect
inflamm
coagul
cascad
hypothes
risk
associ
low
eskd
modifi
fibrinogen
level
patient
method
test
hypothesi
cohort
dialysi
patient
year
followup
result
followup
patient
die
cv
caus
risk
low
level
allcaus
cv
death
strongli
modifi
fibrinogen
level
fulli
adjust
cox
model
includ
age
gender
smoke
diabet
cholesterol
systol
bp
cv
comorbid
hb
phosphat
dialysi
vintag
hazard
ratio
hr
associ
low
level
studi
outcom
lowest
patient
introduct
aim
patient
involv
select
dialysi
method
allow
choos
fit
therapi
psychosocioeconom
statu
could
influenc
short
even
longterm
outcom
howev
investig
romanian
patient
method
questionnair
sent
romanian
renal
registri
patient
start
dialysi
dialysi
unit
public
hospit
larg
privat
dialysi
network
independ
run
privat
dialysi
unit
allaround
countri
selfreport
questionnair
address
patient
percept
overal
satisfact
treatment
modal
item
perceiv
person
involv
decisionmak
process
choos
dialysi
method
item
possibl
way
improv
process
patient
perspect
item
result
respons
receiv
patient
averag
age
year
male
hemodialysi
dialysi
patient
countri
posit
selfpercept
health
qualiti
significantli
relat
psycholog
accept
dialysi
therapi
depend
inform
receiv
emot
health
case
choic
method
made
collabor
patient
physician
although
respond
integr
assum
decis
patient
better
overal
satisfact
dialysi
method
patient
choic
method
made
exclus
physician
trend
lower
qualiti
health
report
p
respond
option
certain
treatment
modal
guid
perceiv
safeti
abil
manag
method
influenc
qualiti
inform
receiv
method
selfperceiv
qualiti
health
relat
either
initi
actual
method
dialysi
actual
method
strongli
correl
initi
method
probabl
chang
initi
method
seem
low
patient
opinion
choic
dialysi
method
could
improv
educ
program
psycholog
assist
conclus
patient
percept
health
qualiti
relat
choic
initi
dialysi
method
howev
low
proport
patient
enough
inform
make
conscienti
choic
feel
program
medic
educ
psycholog
assist
need
predialysi
period
introduct
aim
patient
end
stage
renal
diseas
esrd
treat
dialysi
experi
high
risk
allcaus
cardiovascular
mortal
periton
dialysi
pd
haemodialysi
hd
consid
equal
effect
initi
dialysi
modal
howev
patient
prefer
centr
experi
comorbid
affect
choic
modal
prognost
effect
choic
initi
dialysi
modal
need
explor
aim
util
propens
score
correct
confound
variabl
compar
allcaus
cardiovascular
mortal
patient
treat
pd
hd
initi
dialysi
modal
method
esrd
patient
enter
norwegian
renal
registri
first
time
initi
dialysi
period
januari
decemb
includ
time
depend
propens
score
start
pd
calcul
correct
confound
variabl
time
dialysi
initi
propens
score
adjust
cox
regress
model
use
investig
independ
differ
allcaus
cardiovascular
mortal
hd
pd
case
censor
shift
dialysi
modal
renal
transplant
loss
followup
result
incid
esrd
patient
enter
dialysi
period
count
mean
age
year
men
pd
initi
dialysi
modal
patient
region
differ
use
pd
hd
initi
modal
p
clinic
patient
treat
pd
older
lower
bodi
mass
index
p
higher
egfr
higher
haemoglobin
albumin
level
p
pd
patient
less
establish
heart
diseas
peripher
vascular
diseas
malign
diseas
like
treat
erythropoiesi
stimul
agent
furthermor
patient
initi
pd
like
start
dialysi
plan
manner
p
consid
like
suit
futur
transplant
aetiolog
renal
failur
like
treat
particular
dialysi
modal
p
median
followup
death
censor
month
rang
hd
patient
month
pd
patient
pd
initi
dialysi
modal
independ
associ
alter
risk
allcaus
cardiovascular
mortal
compar
hd
hr
ci
hr
ci
respect
dialysi
modal
also
neutral
concern
allcaus
cardiovascular
mortal
pd
vs
hd
hr
ci
hr
ci
conclus
initi
dialysi
modal
independ
relat
allcaus
cardiovascular
mortal
norwegian
patient
initi
renal
replac
therapi
yuji
sato
shouichi
fujimoto
tatsunori
toida
hideto
nakagawa
univers
miyazaki
hospit
miyazaki
japan
univers
miyazaki
miyazaki
japan
introduct
aim
ntprobnp
marker
volum
overload
myocardi
injuri
report
surviv
predictor
dialysi
patient
term
allcaus
death
cerebrovascular
death
cvd
rel
small
number
patient
conclus
ntprobnp
strong
surviv
predictor
allcaus
death
cvd
modest
signific
predictor
infecti
diseas
death
tumor
death
alexandra
tasmoc
ionut
nistor
mihaela
donciu
luminita
voroneanu
carmen
volovat
adrian
covic
univers
hospit
dr
ci
parhon
iasi
romania
faculti
medicin
univers
medicin
pharmaci
gr
popa
iasi
romania
introduct
aim
pain
symptom
evalu
increasingli
perceiv
import
patient
manag
dialysi
unit
palli
care
institut
littl
experi
use
memori
symptom
assess
scale
shortform
msassf
endstag
renal
diseas
popul
msassf
use
tool
assess
preval
symptom
also
assess
sever
symptom
experienc
patient
object
studi
valid
msassf
romanian
hemodialysi
hd
popul
ii
assess
preval
sever
physic
psycholog
symptom
hemodialysi
patient
use
msassf
iii
determin
qualiti
life
hd
patient
includ
two
summari
score
physic
compon
pc
psycholog
compon
mc
method
seventi
hemodialysi
patient
recrut
assess
intern
reliabl
msassf
differ
group
stabl
patient
male
femal
mean
age
treat
hemodialysi
three
time
weekli
complet
questionnair
preval
sever
symptom
qualiti
life
determin
symptom
preval
sever
hd
patient
msassf
use
determ
qualiti
life
patient
complet
short
form
health
survey
questionnair
cronbach
alpha
reliabl
test
perform
assess
intern
consist
msassf
result
cronbach
alpha
reabil
score
total
number
item
msassf
subscal
msassf
reabil
score
rang
mean
subscal
rang
accept
good
top
three
memori
symptom
experienc
hemodialysi
patient
lack
energi
follow
pain
worri
frequent
report
physic
symptom
includ
lack
energi
pain
numbnesstingl
hand
feet
difficulti
sleep
dri
mouth
dizzi
problem
sexual
interest
activ
frequent
psycholog
symptom
includ
worri
feel
sad
feel
nervou
feel
irrit
mean
physic
compon
summari
pc
qualiti
life
score
mean
mental
compon
summari
mc
qualiti
life
score
statist
relationship
biochem
paramet
msassf
qol
score
found
conclus
result
support
valid
msassf
assess
patient
undergo
hemodialysi
major
concern
hd
patient
lack
energi
pain
caus
symptom
keep
worri
everyth
life
develop
estim
absolut
risk
major
osteoporot
fractur
among
gener
popul
howev
evid
ckd
patient
lack
associ
frax
mortal
unknown
therefor
conduct
hospitalbas
prospect
cohort
studi
evalu
predict
abil
frax
mortal
hemodialysi
patient
method
two
hundr
fiftytwo
patient
start
initi
mainten
hemodialysi
april
decemb
men
women
mean
sd
age
year
studi
endpoint
defin
allcaus
death
cox
proport
hazard
model
use
calcul
hazard
ratio
hr
ci
result
mean
sd
followup
period
year
total
death
observ
median
interquartil
rang
frax
major
osteoporot
fractur
men
women
signific
interact
frax
gender
detect
p
interact
therefor
separ
analys
conduct
men
women
cumul
surviv
point
year
start
dialysi
men
frax
level
median
women
respect
figur
overal
men
multivari
cox
regress
analys
reveal
logtransform
frax
remain
independ
predictor
death
adjust
confound
variabl
model
hr
ci
women
frax
associ
endpoint
tabl
conclus
among
japanes
hemodialysi
patient
frax
level
seem
use
procedur
predict
death
men
women
introduct
aim
advanc
intens
dialysi
contribut
rediscuss
issu
pregnanc
dialysi
patient
spite
renew
interest
improv
result
pregnanc
still
except
dialysi
data
avail
compar
pregnanc
rate
dialysi
kidney
transplant
also
respect
overal
popul
aim
studi
assess
incid
liveborn
babi
mother
chronic
dialysi
itali
new
millennium
compar
result
overal
popul
kidney
transplant
patient
interestingli
half
mother
residu
diuresi
long
dialysi
vintag
one
third
immunolog
diseas
includ
sle
vascul
thu
suggest
pregnanc
possibl
also
long
dialysi
followup
difficult
diseas
preterm
deliveri
rule
singleton
avail
data
preterm
earli
preterm
ie
gestat
week
preval
children
weight
percentil
gestat
ageadjust
high
three
babi
die
first
month
life
includ
one
twin
surviv
children
clinic
development
problem
common
therapeut
adjust
switch
daili
dialysi
increas
exchang
periton
dialysi
expect
compar
data
pregnanc
record
kidney
graft
italian
graft
popul
birth
weight
lower
dialysi
vs
g
p
gestat
age
also
lower
vs
week
p
incid
liveborn
babi
infer
per
femal
dialysi
patient
childbear
age
age
year
per
graft
patient
age
group
figur
correspond
livebirth
rate
italian
popul
per
women
age
year
conclus
babi
dialysi
rare
imposs
earli
mortal
remain
high
scale
probabl
fold
decreas
probabl
liveborn
babi
overal
popul
transplant
transplant
dialysi
introduct
aim
viscer
adipos
index
vai
newlyderiv
measur
viscer
adipos
wellvalid
predict
power
cardiovascular
cv
outcom
gener
popul
howev
predict
investig
hemodialysi
hd
patient
whether
vai
superior
waist
circumfer
wc
waisttoheight
ratio
whtr
predict
cv
outcom
surviv
hd
patient
remain
unknown
method
perform
prospect
studi
preval
hemodialysi
patient
enrol
composit
outcom
occurr
death
cv
event
followup
use
multivari
cox
regress
model
vai
wc
whtr
test
predict
power
composit
outcom
allcaus
mortal
result
vai
wc
whtr
posit
correl
patient
higher
vai
tertil
vs
tertil
adjust
hazard
ratio
hr
confid
interv
ci
tertil
vs
tertil
adjust
hr
ci
composit
outcom
vai
similar
predict
power
composit
cv
outcom
wc
whtr
superior
predict
power
allcaus
mortal
wc
whtr
analyz
receiv
oper
characterist
curv
conclus
vai
optim
method
measur
viscer
adipos
assess
longterm
cv
outcom
allcaus
mortal
preval
hd
patient
vai
may
provid
superior
predict
power
allcaus
mortal
wc
whtr
introduct
aim
optim
time
initi
dialysi
end
stage
renal
diseas
patient
still
controversi
question
studi
done
recent
challeng
earli
initi
trend
dialysi
conduct
studi
evalu
relationship
gfr
mortal
hemodialysi
hd
patient
beij
method
total
incid
hd
patient
enrol
databas
januari
decemb
egfr
estim
ckdepi
equat
accord
creatinin
start
dialysi
patient
classifi
five
group
base
egfr
group
group
group
group
group
kaplanmei
cox
regress
analys
perform
assess
associ
egfr
allcaus
mortal
cox
regress
model
includ
predialysi
egfr
age
gender
primari
renal
diseas
result
egfr
dialysi
initi
six
year
followup
patient
die
cox
regress
model
reveal
increas
mortal
risk
higher
egfr
group
group
also
group
compar
group
adjust
age
gender
primari
renal
diseas
chronic
glomerulonephr
diabet
nephropathi
hypertens
nephropathi
chronic
tubulointerstiti
nephriti
polycyst
kidney
diseas
other
conclus
initi
dialysi
higher
level
egfr
associ
increas
mortal
hd
patient
long
followup
period
meanwhil
low
egfr
might
also
induc
higher
mortal
factor
relat
need
studi
littl
known
kidney
function
volunt
recruit
healthi
control
report
kidney
function
individu
method
solicit
particip
healthi
volunt
use
poster
newspap
telephon
caller
underw
structur
question
explor
elig
volunt
pass
telephon
interview
underw
clinic
assess
height
weight
blood
pressur
measur
serum
creatinin
bun
urinalysi
week
later
estim
glomerular
filtrat
rate
egfr
comput
ckdepi
equat
albumincreatinin
ratio
acr
calcul
urin
albuminurin
creatinin
mgg
systol
blood
pressur
sbp
record
three
consecut
time
sit
posit
subject
averag
sbp
mmhg
consid
hypertens
result
base
phone
interview
almost
volunt
exclud
kidney
cardiac
malignancyrel
condit
ninetyon
particip
age
year
femal
elig
particip
exclud
mostli
absent
blood
urin
sampl
result
obtain
remain
particip
shown
tabl
age
significantli
differ
egfr
group
p
anova
result
indic
presenc
unrecogn
kidney
impair
notabl
fraction
normal
healthi
volunt
identifi
healthi
pass
telephon
interview
screen
aim
identifi
exclud
nonhealthi
volunt
sinc
decreas
function
unknown
caus
frequent
older
peopl
consid
recruit
appar
healthi
volunt
introduct
aim
purpos
studi
evalu
healthrel
qualiti
life
patient
undergo
high
convect
volum
onlin
hemodiafiltr
contribut
current
controversi
discuss
regard
onlin
hemodiafiltr
method
studi
end
stage
renal
diseas
patient
treat
ambulatori
healthcar
centr
year
hemodialysi
patient
treat
onlin
hemodiafiltr
offer
particip
option
assess
healthrel
qualiti
life
select
bia
within
centr
total
patient
assess
perform
kidney
diseas
qualiti
life
short
form
base
public
dialysi
outcom
practic
pattern
studi
socioeconom
clinic
data
patient
use
estim
expect
healthrel
qualiti
life
score
expect
score
subsequ
compar
actual
score
indic
patient
pair
ttest
result
questionnair
return
respons
rate
mean
age
analyz
patient
year
male
mean
convect
volum
l
l
median
l
sever
domain
concern
healthrel
qualiti
life
patient
undergo
onlin
hemodiafiltr
report
significantli
higher
score
predict
model
domain
includ
physic
compon
summari
p
physic
function
p
pain
gener
health
p
social
function
mental
health
symptom
problem
cognit
function
p
conclus
contrast
studi
data
suggest
healthrel
qualiti
life
endstag
renal
diseas
patient
benefit
onlin
hemodiafiltr
though
randomis
control
trial
studi
might
contribut
current
discuss
regard
onlin
hemodiafiltr
high
convect
volum
patient
group
note
might
explain
discrep
result
studi
howev
data
result
one
centr
exclud
select
bia
research
need
institut
nephrolog
nam
ukrain
kyiv
ukrain
introduct
aim
candidiasi
common
opportunist
infect
immunocompromis
patient
infect
major
caus
morbid
mortal
patient
end
stage
renal
failur
esrf
esrf
patient
haemodialysi
hd
high
frequenc
nutrit
immunolog
psycholog
disord
well
disord
invas
procedur
antimicrobi
treatment
known
contribut
presenc
higher
number
yeast
coloni
aim
studi
local
preval
fungal
colon
subsequ
evalu
medium
term
outcom
hd
patient
conclus
jsdt
recommend
dialysi
condit
determin
achiev
predialysi
serum
level
maximum
interv
mgl
studi
less
predialysi
serum
level
lower
mortal
dialysi
patient
independ
age
haemodialysi
durat
presenc
diabet
predialysi
serum
albumin
blood
urea
nitrogen
point
view
guidelin
appropri
therefor
may
design
dialysi
condit
achiev
effect
remov
introduct
aim
hemodialysi
patient
lack
normal
homeostat
mechan
regul
bodi
water
volum
osmol
howev
seem
individu
osmolar
set
point
dialys
posit
sodium
gradient
might
associ
increas
interdialyt
weight
gain
blood
pressur
therefor
individu
sodium
prescript
approach
may
benefici
method
conduct
crosssect
studi
hospit
base
hemodialysi
unit
period
month
compris
clinic
stabl
patient
hemodialysi
descript
analysi
patient
sodium
dialysi
prescript
analyt
clinic
data
assess
statist
analysi
result
analysi
prescript
clinic
data
patient
compris
studi
found
dialys
sodium
prescript
rang
median
meql
mean
prehd
serum
sodium
result
mean
sodium
gradient
major
patient
dialys
posit
sodium
gradient
found
direct
correl
sodium
gradient
idwg
p
sodium
gradient
percent
idwg
idwg
p
sodium
gradient
number
intradialyt
hypotens
episod
p
adjust
confound
age
dialysi
vintag
dri
weight
sodium
gradient
independ
associ
idwg
p
found
signific
associ
either
sodium
gradient
blood
pressur
control
number
antihypertens
agent
hospit
medic
complic
death
conclus
despit
small
sampl
possibl
find
statist
signific
sodium
gradient
idwg
idwg
intradialyt
hypotens
episod
suggest
import
individu
hemodialysi
sodium
prescript
order
look
align
dialys
sodium
serum
sodium
concentr
hannah
curri
j
baharani
heart
england
nh
foundat
trust
birmingham
unit
kingdom
introduct
aim
endstag
renal
diseas
esrd
associ
cognit
impair
ci
estim
mani
haemodialysi
hd
patient
age
year
moder
sever
ci
pathophysiolog
remain
unclear
effect
undeni
paradigm
shift
elderli
patient
ever
need
hd
singl
studi
conduct
amongst
haemodialysi
patient
age
year
older
found
cognit
function
significantli
lower
dialysi
session
compar
shortli
follow
day
dialysi
aim
pilot
studi
assess
effect
singl
haemodialysi
session
cognit
function
establish
stabl
haemodialysi
patient
method
patient
age
establish
hd
month
prior
document
memori
impair
includ
patient
randomli
select
local
haemodialysi
cohort
invit
particip
prior
dialysi
session
complet
mmse
score
assess
use
montreal
cognit
assess
tool
moca
moca
onepag
test
administ
approxim
minut
version
enabl
reus
short
space
time
patient
complet
baselin
prior
commenc
hd
hour
dialysi
within
hour
complet
session
result
patient
agre
particip
exclud
score
mmse
patient
f
ratio
mean
age
year
rang
complet
cognit
test
caucasian
mean
durat
dialysi
month
month
diabet
dialys
via
fistula
mean
karnofski
score
low
comorbid
group
mean
baselin
mmse
mean
hour
mean
recoveri
baselin
moca
score
cohort
reveal
mild
moder
ci
evid
mmse
evid
ci
worsen
dialysi
fulli
revers
fell
cohort
follow
complet
dialysi
conclus
pilot
show
ci
present
three
quarter
patient
age
year
receiv
long
term
hd
despit
presenc
ci
patient
reason
function
score
despit
moder
high
comorbid
ci
worsen
hd
half
group
fulli
recov
worsen
end
session
rais
implic
short
term
travel
home
alon
empti
home
hd
long
term
wider
implic
share
diagnosi
ci
patient
goe
hand
hand
futur
plan
care
prognosi
outlook
creat
global
havoc
high
case
fatal
rate
natur
histori
infect
hemodialysi
hd
patient
studi
well
best
knowledg
largest
singl
center
case
seri
report
merscov
infect
hemodialysi
patient
popul
patient
admit
princ
sultan
militari
medic
citi
psmcc
nephrolog
ward
outcom
report
studi
method
four
consecut
patient
includ
report
patient
isol
diagnosi
made
pcr
clinic
present
total
hospit
stay
ventil
requir
mortal
rate
studi
three
serial
blood
sputum
urin
cultur
done
exclud
possibl
bacteri
fungal
sepsi
result
three
patient
male
median
age
year
diabet
hypertens
infect
patient
recent
start
hd
perman
cathet
mean
averag
premorbid
durat
dialysi
day
fourth
patient
dialysi
fistula
day
infect
averag
hospit
stay
day
present
pneumonia
clinic
radiolog
criteria
present
lymphopenia
fever
none
associ
perman
cathet
infect
one
receiv
intraven
immunoglobulin
discharg
home
week
requir
ventil
support
hospit
stay
need
mechan
ventil
eventu
die
due
multipl
organ
failur
one
patient
flue
like
symptom
recov
fulli
without
intervent
kept
hospit
week
pcr
becam
neg
merscov
conclus
merscov
infect
hd
patient
prolong
hospit
stay
associ
higher
mortal
thu
contrast
non
hd
popul
result
particip
report
moder
burden
sever
accord
zbi
classif
baselin
followup
assess
although
anova
comparison
indic
statist
signific
increas
caregiv
burden
p
followup
particip
also
report
poorer
qol
outcom
term
psycholog
health
p
followup
addit
overal
qol
level
found
wors
rel
gener
popul
norm
domain
baselin
followup
assess
symptom
anxieti
depress
measur
higher
caregiv
reach
threshold
score
moder
sever
burden
per
zbi
classif
high
burden
caregiv
also
found
provid
care
older
patient
p
conclus
overal
result
suggest
caregiv
pd
patient
experi
increas
burden
time
risk
anxieti
depress
poor
psycholog
health
pd
regim
offer
flexibl
autonomi
patient
may
result
increas
caregiv
burden
time
due
factor
requir
assist
manag
multipl
technic
aspect
pd
exchang
addit
invers
relationship
patient
age
caregiv
qol
document
suggest
need
understand
variou
clinic
need
differ
age
group
pd
patient
may
translat
differ
burden
caregiv
studi
result
rais
question
way
promot
well
context
pd
famili
unit
address
psychosoci
need
pd
caregiv
popul
method
individu
includ
studi
follow
preand
postop
data
analyz
demographi
cardiovascular
respiratori
comorbid
dialysi
time
diuresi
bp
variat
apach
ii
score
preoper
emg
assess
degre
autonom
neuropathi
complex
surgic
procedur
type
anesthesia
level
crp
hemoglobin
albumin
clinic
statu
discharg
patient
surgic
relatedinfect
improv
clinic
statu
valu
albumin
hemoglobin
crp
repres
group
rest
subject
form
group
b
analyz
data
use
chisquar
test
compar
find
group
calcul
rel
risk
confid
interv
p
result
percentag
patient
receiv
spinal
anesthesia
significantli
higher
group
b
versu
group
increas
poor
outcom
preval
postop
hypotens
event
compar
gener
anesthesia
p
addit
elev
preoper
degre
autonom
neuropathi
strongli
correl
hypotens
episod
spinal
anesthesia
chisquar
df
p
conclus
chronic
dialyz
patient
receiv
spinal
anesthesia
present
often
unfavor
prognosi
hypotens
event
risk
sympathet
blockad
studi
highlight
gener
anesthesia
offer
better
global
control
differ
bioumor
variabl
eg
hemoglobin
albumin
especi
sinc
use
new
volatil
agent
furthermor
preoper
emg
find
may
use
predict
risk
hypotens
episod
spinal
anesthesia
chronic
dialyz
individu
extens
clinic
trial
need
support
result
choos
right
anesthesia
type
perform
preoper
emg
routin
group
popul
stepwis
multivari
logist
regress
backward
select
perform
result
mean
index
score
variabl
show
signific
associ
depress
p
anxieti
p
support
friend
p
cognit
function
insomnia
durat
hd
albumin
bmi
multipl
regress
show
anxieti
p
cognit
function
bmi
independ
predictor
impair
qualiti
life
conclus
studi
explor
determin
high
suscept
impair
qualiti
life
hd
patient
found
impair
qualiti
life
associ
anxieti
cognit
function
bmi
consid
psychosoci
factor
well
clinic
one
improv
qualiti
life
hd
patient
leszek
domanski
karolina
tomasz
prystacki
krzysztof
safranow
violetta
dziedziejko
kazimierz
ciechanowski
pomeranian
medic
univers
szczecin
szczecin
poland
introduct
aim
hemodialysi
hd
remain
main
method
end
stage
renal
diseas
esrd
therapi
poland
wellb
patient
undergo
dialysi
measur
assess
dialysi
effect
biochem
blood
paramet
evalu
dialysi
index
estim
use
singl
pool
ktv
urea
reduct
ratio
urr
standard
measur
use
quantifi
hd
treatment
adequaci
aim
studi
analysi
dialysi
center
dc
modern
manag
associ
patient
health
statu
evalu
hd
effect
anemia
sever
iron
metabol
blood
pressur
control
ca
p
concentr
method
retrospect
review
hd
patient
medic
record
perform
individu
origin
dc
began
manag
effici
differ
time
point
analyz
hd
adequaci
express
spktv
urr
moreov
current
durat
hd
hour
per
week
total
time
hd
treatment
month
also
record
patient
anemia
sever
iron
fe
metabol
paramet
assess
serum
concentr
ca
p
ca
x
p
product
evalu
final
subject
systol
sbp
diastol
blood
pressur
dbp
note
mean
arteri
pressur
map
estim
result
averag
hd
durat
per
week
total
time
hd
treatment
significantli
longer
manag
time
period
p
p
respect
effect
dialysi
measur
urr
spktv
significantli
higher
manag
dc
p
p
respect
anemia
sever
iron
metabol
paramet
hb
ferritin
administr
esa
per
week
per
kg
bodi
weight
administr
fe
per
week
differ
significantli
unmanag
manag
time
period
p
p
p
p
respect
p
concentr
ca
x
p
product
significantli
lower
manag
time
period
p
p
respect
dbp
map
significantli
lower
manag
time
period
respect
conclus
result
studi
confirm
modern
manag
dialysi
center
improv
patient
health
statu
evalu
hd
effect
anemia
sever
iron
metabol
blood
pressur
control
ca
p
concentr
tallinn
univers
technolog
tallinn
estonia
univers
sweden
north
estonian
medic
centr
tallinn
estonia
introduct
aim
report
mean
life
expect
hemodialysi
patient
less
year
therefor
marker
method
patient
outcom
estim
highli
long
wide
use
small
molecular
weight
marker
estim
kidney
function
dialysi
adequaci
creatinin
urea
use
urea
nitrogen
appear
serumurinedialys
allow
calcul
pna
protein
nitrogen
appear
andor
npna
normal
pna
estim
nutrit
statu
dialysi
patient
sever
studi
suggest
high
level
uric
acid
ua
may
play
import
role
develop
hypertens
renal
diseas
cardiovascular
event
region
ua
consid
essenti
molecul
monitor
dialysi
patient
purpos
studi
examin
simultan
monitor
two
small
molecul
urem
marker
urea
ua
could
relat
surviv
dialysi
patient
